<?xml version="1.0" encoding="utf-8" ?><rss version="2.0"><channel><title>Bing: Full-Stack Task Management System</title><link>http://www.bing.com:80/search?q=Full-Stack+Task+Management+System</link><description>Search results</description><image><url>http://www.bing.com:80/s/a/rsslogo.gif</url><title>Full-Stack Task Management System</title><link>http://www.bing.com:80/search?q=Full-Stack+Task+Management+System</link></image><copyright>Copyright © 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>What is hepatocellular carcinoma in dogs and what does latest evidence ...</title><link>https://www.primveterinary.com/ask/hepatocellular-carcinoma-dogs-treatment</link><description>Summary Hepatocellular carcinoma (HCC) is the most frequent malignant primary liver tumor in dogs, with massive, nodular, and diffuse forms being the recognized morphologic subtypes [1][2].</description><pubDate>Tue, 10 Nov 2026 14:23:00 GMT</pubDate></item><item><title>Treatment Options | Canine HCC | Burbs Blurbs</title><link>https://www.burbsblurbs.com/resources/treatment-options-canine-hepatocellular-carcinoma</link><description>Surgical Resection Surgical removal of the tumor is a commonly considered treatment approach for dogs with hepatocellular carcinoma when the tumor is localized (confined to one area of the liver) and surgically resectable, as may be the case with massive HCC. Gibson et al.; Marconato et al. Multiple retrospective studies have evaluated survival outcomes in dogs undergoing surgical resection ...</description><pubDate>Sat, 24 Oct 2026 03:58:00 GMT</pubDate></item><item><title>Hepatocellular Carcinoma in Dogs — Treatment Options, Survival &amp; Costs ...</title><link>https://www.petcanceroptions.com/canine/canine-hepatocellular-carcinoma/</link><description>About This Cancer Hepatocellular carcinoma is the most common primary liver cancer in dogs, arising from hepatocytes — the main functional cells of the liver. It occurs in three distinct forms: massive (a single large tumour in one liver lobe, about 55% of cases), nodular (multiple tumour nodules across the liver, about 30%), and diffuse (cancer spread throughout the liver, about 15%). This ...</description><pubDate>Wed, 04 Nov 2026 22:29:00 GMT</pubDate></item><item><title>Use of imaging-guided intensity-modulated stereotactic body radiation ...</title><link>https://avmajournals.avma.org/view/journals/javma/259/4/javma.259.4.392.xml</link><description>In the 10-month period after completion of radiation therapy, the hepatocellular mass continued to decrease in size, and overall improvements in the dog's serum liver enzyme abnormalities were evident. CLINICAL RELEVANCE There are few treatment options for dogs with incompletely excised hepatocellular carcinomas.</description><pubDate>Mon, 09 Nov 2026 02:49:00 GMT</pubDate></item><item><title>Case report: Toceranib as adjuvant chemotherapy in a dog with ...</title><link>https://www.researchgate.net/publication/366851058_Case_report_Toceranib_as_adjuvant_chemotherapy_in_a_dog_with_incompletely_resected_combined_hepatocellular-cholangiocarcinoma</link><description>Six dogs with massive hepatocellular carcinoma that was not amenable to surgery were treated by oral administration of single-agent toceranib at a dose of 2.0-3.0 mg/kg every other day for a ...</description><pubDate>Thu, 25 May 2023 18:16:00 GMT</pubDate></item><item><title>Case report: Toceranib as adjuvant chemotherapy in a dog ... - Frontiers</title><link>https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2022.963390/full</link><description>The tissue was submitted for histopathologic evaluation, and the patient was diagnosed with stage IIIA combined hepatocellular-cholangiocarcinoma (cHCC-CC). Considering the residual tumor tissue from incomplete surgical excision, adjuvant chemotherapy was recommended.</description><pubDate>Tue, 03 Jan 2023 23:56:00 GMT</pubDate></item><item><title>Treatments for Dogs with Liver Cancer - ccralliance.org</title><link>https://www.ccralliance.org/post/treatments-for-dogs-with-liver-cancer</link><description>Liver cancer is relatively rare in dogs, accounting for less than 1.5% of all tumors. The most common type of primary liver cancer is hepatocellular carcinoma (HCC), which accounts for about 50% of malignant liver tumors in dogs. This type of cancer typically grows slowly, and when diagnosed early, it offers a better prognosis as surgical removal may be possible.</description><pubDate>Mon, 09 Nov 2026 19:10:00 GMT</pubDate></item><item><title>Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma ...</title><link>https://pmc.ncbi.nlm.nih.gov/articles/PMC7281367/</link><description>In dogs, hepatocellular carcinoma (HCC) is the most common primary liver tumor [1, 2], and its prognosis depends on the morphological type. The massive form is typically confined to one liver lobe and may be amenable to surgical resection [3].</description><pubDate>Tue, 13 Oct 2026 20:25:00 GMT</pubDate></item><item><title>Hepatocellular Carcinoma in Dogs: Understanding This Common Liver Cancer</title><link>https://blog.fidocure.com/fidocure-blog/hepatocellular-carcinoma-in-dogs-understanding-this-common-liver-cancer</link><description>Hepatocellular carcinoma (HCC) is the most common primary liver cancer in dogs. It can present as a single mass, multiple nodules, or diffuse spread throughout the liver, which increases the risk of metastasis. The main treatment options are surgical removal, metronomic chemotherapy, and/or Palladia.</description><pubDate>Wed, 04 Nov 2026 06:52:00 GMT</pubDate></item><item><title>Case report: Toceranib as adjuvant chemotherapy in a dog with ...</title><link>https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2022.963390/pdf</link><description>The tissue was submitted for histopathologic evaluation, and the patient was diagnosed with stage IIIA combined hepatocellular-cholangiocarcinoma (cHCC-CC). Considering the residual tumor tissue from incomplete surgical excision, adjuvant chemotherapy was recommended.</description><pubDate>Sun, 08 Nov 2026 05:57:00 GMT</pubDate></item></channel></rss>